Terms: = Germ cell tumor AND CD274, PDL1, 29126, ENSG00000120217, PDCD1L1, PD-L1, MGC142296, PDCD1LG1, MGC142294, B7H1, Q9NZQ7, B7-H
1807 results:
1. The immune response-related genomic alterations in patients with malignant melanoma.
Li L; Xiang T; Li X
Medicine (Baltimore); 2024 Apr; 103(17):e37966. PubMed ID: 38669390
[TBL] [Abstract] [Full Text] [Related]
2. Identification of prognostic m6A modification patterns and score system in melanoma patients.
Wang F; Chen P; Ouyang S; Xiong K; Liu Z; Wang Y
Medicine (Baltimore); 2024 Apr; 103(17):e37950. PubMed ID: 38669381
[TBL] [Abstract] [Full Text] [Related]
3. Intratumor injection of BCG Ag85A high-affinity peptides enhanced anti-tumor efficacy in PPD-positive melanoma.
Qin L; Zhang G; Wu Y; Yang Y; Zou Z
Cancer Immunol Immunother; 2024 Apr; 73(6):103. PubMed ID: 38630135
[TBL] [Abstract] [Full Text] [Related]
4. In Silico Transcriptomic Expression of MSR1 in Solid tumors Is Associated with Responses to Anti-PD1 and Anti-CTLA4 Therapies.
Sanvicente A; Díaz-Tejeiro C; Nieto-Jiménez C; Paniagua-Herranz L; López Cade I; Balázs G; Moreno V; Pérez-Segura P; Calvo E; Ocaña A
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612803
[TBL] [Abstract] [Full Text] [Related]
5. Oleoylethanolamide and Palmitoylethanolamide Enhance IFNβ-Induced Apoptosis in Human Neuroblastoma SH-SY5Y cells.
Camoglio C; Balla J; Fadda P; Dedoni S
Molecules; 2024 Apr; 29(7):. PubMed ID: 38611871
[TBL] [Abstract] [Full Text] [Related]
6. OMA1 competitively binds to HSPA9 to promote mitophagy and activate the cGAS-STING pathway to mediate GBM immune escape.
Zhu W; Rao J; Zhang LH; Xue KM; Li L; Li JJ; Chen QZ; Fu R
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38604814
[TBL] [Abstract] [Full Text] [Related]
7. Relevance of Thymic Stromal Lymphopoietin on the Pathogenesis of Glioblastoma: Role of the Neutrophil.
Infante Cruz A; Coronel JV; Saibene Vélez P; Remes Lenicov F; Iturrizaga J; Abelleyro M; Rosato M; Shiromizu CM; Candolfi M; Vermeulen M; Jancic C; Yasuda E; Berner S; Villaverde MS; Salamone GV
Cell Mol Neurobiol; 2024 Apr; 44(1):31. PubMed ID: 38557942
[TBL] [Abstract] [Full Text] [Related]
8. Potential value of expression of receptor accessory protein 4 for evaluating the prognosis of lower-grade glioma patients.
Luo S; Liu Z; Chang H; Cheng X; Qian R; Gao Y; Hou C
Aging (Albany NY); 2024 Mar; 16(7):6188-6211. PubMed ID: 38552216
[TBL] [Abstract] [Full Text] [Related]
9. IL-6-Driven Autocrine Lactate Promotes Immune Escape of Uveal Melanoma.
Gong C; Yang M; Long H; Liu X; Xu Q; Qiao L; Dong H; Liu Y; Li S
Invest Ophthalmol Vis Sci; 2024 Mar; 65(3):37. PubMed ID: 38551584
[TBL] [Abstract] [Full Text] [Related]
10. Analyses of tertiary lymphoid structures observed in cases of Merkel cell carcinoma showing spontaneous regression.
Nakamura M; Yoshimitsu M; Magara T; Kano S; Kato H; Morita A
Exp Dermatol; 2024 Mar; 33(3):e15062. PubMed ID: 38532566
[TBL] [Abstract] [Full Text] [Related]
11. SESN1 functions as a new tumor suppressor gene via Toll-like receptor signaling pathway in neuroblastoma.
Hua Z; Chen B; Gong B; Lin M; Ma Y; Li Z
CNS Neurosci Ther; 2024 Mar; 30(3):e14664. PubMed ID: 38516781
[TBL] [Abstract] [Full Text] [Related]
12. Density of high endothelial venules and PDL-1 expression: relationship with tumor-infiltrating lymphocytes in primary cutaneous melanomas.
Stolfo JB; Motta ACD
An Acad Bras Cienc; 2024; 96(1):e20230441. PubMed ID: 38511744
[TBL] [Abstract] [Full Text] [Related]
13. An advanced comprehensive muti-cell-type-specific model for predicting anti-PD-1 therapeutic effect in melanoma.
Sun W; Zhu Y; Zou Z; Wang L; Zhong J; Shen K; Lin X; Gao Z; Liu W; Li Y; Xu Y; Ren M; Hu T; Wei C; Gu J; Chen Y
Theranostics; 2024; 14(5):2127-2150. PubMed ID: 38505619
[No Abstract] [Full Text] [Related]
14. Retrospective Analyses of pd-l1, LAG-3, TIM-3, OX40L Expressions and MSI Status in Gastroenteropancreatic Neuroendocrine Neoplasms.
Gürler F; Aktürk Esen S; Kurt İnci B; Sütçüoğlu O; Uçar G; Akdoğan O; Uncu D; Turhan N; Akyürek N; Özdemir N; Özet A; Yazıcı O
Cancer Invest; 2024 Feb; 42(2):141-154. PubMed ID: 38486421
[TBL] [Abstract] [Full Text] [Related]
15. Targeting Wnt signaling for improved glioma immunotherapy.
Gutova M; Hibbard JC; Ma E; Natri HM; Adhikarla V; Chimge NO; Qiu R; Nguyen C; Melendez E; Aguilar B; Starr R; Yin H; Rockne RC; Ono M; Banovich NE; Yuan YC; Brown CE; Kahn M
Front Immunol; 2024; 15():1342625. PubMed ID: 38449858
[TBL] [Abstract] [Full Text] [Related]
16. Merkel cell Carcinoma of Unknown Primary Origin.
Francetić H; Simetić L; Tomasović Lončarić Č; Štulhofer Buzina D; Čeović R
Acta Dermatovenerol Croat; 2023 Dec; 31(3):153-155. PubMed ID: 38439727
[TBL] [Abstract] [Full Text] [Related]
17. Metabolic remodeling by the pd-l1 inhibitor BMS-202 significantly inhibits cell malignancy in human glioblastoma.
Yang X; Wang W; Ji T
Cell Death Dis; 2024 Mar; 15(3):186. PubMed ID: 38438374
[TBL] [Abstract] [Full Text] [Related]
18. Role of immune checkpoint inhibitors combined with chemotherapy in recurrent drug-resistant gestational trophoblastic neoplasia: Four case reports and literature review.
Liu W; Zhu Y; Wang Y; Li R; Zou D; Chen R; Yang L; Huang Y
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2016. PubMed ID: 38425251
[TBL] [Abstract] [Full Text] [Related]
19. Targeted deletion of CD244 on monocytes promotes differentiation into anti-tumorigenic macrophages and potentiates pd-l1 blockade in melanoma.
Kim J; Kim TJ; Chae S; Ha H; Park Y; Park S; Yoon CJ; Lim SA; Lee H; Kim J; Kim J; Im K; Lee K; Kim J; Kim D; Lee E; Shin MH; Park SI; Rhee I; Jung K; Lee J; Lee KH; Hwang D; Lee KM
Mol Cancer; 2024 Feb; 23(1):45. PubMed ID: 38424542
[TBL] [Abstract] [Full Text] [Related]
20. A novel mitochondria-targeting DHODH inhibitor induces robust ferroptosis and alleviates immune suppression.
Hai Y; Fan R; Zhao T; Lin R; Zhuang J; Deng A; Meng S; Hou Z; Wei G
Pharmacol Res; 2024 Apr; 202():107115. PubMed ID: 38423231
[TBL] [Abstract] [Full Text] [Related]
[Next]
